<?xml version="1.0" encoding="UTF-8"?>
<p>There is no standardized treatment for hepatitis E. The best therapeutic option for transplant recipients is ribavirin, interferon, or a combination thereof, depending on the grafted organ. The vaccines developed are based on 
 <italic>HEV1</italic>. Further research must be directed towards the development of HEV vaccines based on immunodominant epitopes of all four human genotypes of HEV.
</p>
